Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-06

Clinical Trial Update: Examining Hair to Determine Tenofovir Exposure [Phase 1]

View source ↗

Summary

A Phase 1 trial investigates using hair samples to gauge exposure to tenofovir in people with HIV. The study status is Completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Public Health Foundation Enterprises, Inc. | Conditions: HIV | Phase 1 | Status: COMPLETED